← FDA DRUG APPROVALS

FDA ANDA · ANDA073306

CLOTRIMAZOLE

Sponsor: TEVA

APPLICATION
ANDA073306
TYPE
ANDA
ORIGINAL APPROVAL
1995-02-28
LATEST ACTION
2002-12-20
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

CLOTRIMAZOLEPrescription
CLOTRIMAZOLE 1% · SOLUTION · TOPICAL

Approval history

2002-12-20Manufacturing (CMC) · Supplement 10AP
2002-05-29Manufacturing (CMC) · Supplement 9AP
2001-08-30Manufacturing (CMC) · Supplement 8AP
2000-07-07Manufacturing (CMC) · Supplement 6AP
2000-02-04Manufacturing (CMC) · Supplement 4AP
2000-02-04Manufacturing (CMC) · Supplement 5AP
1998-01-28Manufacturing (CMC) · Supplement 3AP
1997-06-23Manufacturing (CMC) · Supplement 2AP
1996-10-18Manufacturing (CMC) · Supplement 1AP
1995-02-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →